EUVIMEDEUVIMED entdecken
Crossref

Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions

Sean A Fletcher iD, Mark N Alshak, Seoho Lee, Nirmish Singla, Misop Han, Mohamad E Allaf, Arvin K George, Katarzyna J Macura, Christian P Pavlovich iD

BJU International · 2025-10 · 136 (4) · 669-674

DOI: 10.1111/bju.16816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 12.06.2025. Verfasst von Sean A Fletcher und 8 weiteren Autor:innen. Beteiligte Einrichtung: The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging, Image-Guided Biopsy, Prostate. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterise the prevalence and distribution of biopsy cores found to be higher grade on systematic biopsy compared to targeted biopsy in patients with prostate magnetic resonance imaging (MRI) lesions. Patients and Methods We retrospectively identified patients with a pre‐biopsy MRI and a Prostate Imaging‐Reporting and Data System score ≥3 lesion, who underwent combined systematic and targeted biopsy between 2021 and 2024. Transrectal and transperineal approaches with either software‐based or cognitive fusion techniques were used. We compared the highest Gleason grade detected by systematic vs targeted biopsy for each patient. Clinically significant prostate cancer (csPCa) was defined as Gleason Grade Group ≥2. For those with higher‐grade csPCa detected on systematic compared to targeted biopsy, we correlated the pathological location of the higher‐grade systematic core to the corresponding MRI region(s) of interest (ROI). Multivariable logistic regression was used to determine factors associated with higher‐grade csPCa found on systematic biopsy.

Results

Our final cohort comprised 481 patients. Detection of higher‐grade csPCa on systematic biopsy outside of the MRI ROI occurred in 6.4% of all cases. Systematic biopsy detected higher‐grade csPCa contralateral to the MRI ROI in only 1.5% of all cases. There were no identifiable factors on multivariable analysis associated with detection of higher‐grade csPCa on systematic biopsy outside of the ROI.

Conclusion

There exists a small percentage of patients with occult csPCa detected only on systematic biopsy outside of the MRI ROI, most of which is ipsilateral to the target. Systematic biopsy also increased detection of low‐grade cancer overall. An approach of systematic biopsy ipsilateral to MRI lesions should increase csPCa detection while reducing overdiagnosis of low‐grade disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMagnetic Resonance ImagingImage-Guided BiopsyProstateHumansMaleRetrospective StudiesAgedMiddle AgedNeoplasm Grading

Stichwörter der Autor:innen

MRIearly detectionprostate cancersystematic biopsytargeted biopsy

Autor:innen und Institutionen

  • The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • The Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Sean A Fletcher, Christian P Pavlovich

Zitieren

APA

Fletcher, S. A., Alshak, M. N., Lee, S., Singla, N., Han, M., Allaf, M. E., George, A. K., Macura, K. J., & Pavlovich, C. P. (2025). Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions. BJU International, 136(4), 669-674. https://doi.org/10.1111/bju.16816

Vancouver

Fletcher SA, Alshak MN, Lee S, Singla N, Han M, Allaf ME, et al. Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions. BJU International. 2025;136(4):669-674. doi:10.1111/bju.16816

BibTeX
@article{Fletcher2025,
  author = {Fletcher, Sean A and Alshak, Mark N and Lee, Seoho and Singla, Nirmish and Han, Misop and Allaf, Mohamad E and George, Arvin K and Macura, Katarzyna J and Pavlovich, Christian P},
  title = {Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions},
  journal = {BJU International},
  year = {2025},
  volume = {136},
  number = {4},
  pages = {669--674},
  doi = {10.1111/bju.16816}
}
Kostenlos starten →